MULTI-EPITOPIC CONSTRUCT

To provide an effective treatment for atherosclerosis.SOLUTION: Provided are a recombinant construct and immunogenic and vaccine compositions each comprising (i) a scaffold portion, (ii) a first species of epitope capable of eliciting an anti-arteriosclerotic vascular disease response via a first pathway, and (iii) a second species of epitope capable of eliciting an anti-arteriosclerotic vascular disease via a second pathway that is independent from the first pathway. The epitope is associated with different pathways leading to atherosclerosis. In particular, such compositions elicit immune responses against antigens and pathogens involved in the development of atherosclerosis. Also provided are an inter alia method of treating and/or preventing the disease and a recombinant protein product.SELECTED DRAWING: None.

Medienart:

Patent

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Europäisches Patentamt - (2021) vom: 18. Feb. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

VIJAY KAKKAR [VerfasserIn]
LU XINJIE [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
bio
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2021-02-18, Last update posted on www.tib.eu: 2023-09-27, Last updated: 2023-10-06

Patentnummer:

JP2021019614

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA007073739